Literature DB >> 21727229

Varenicline for smoking cessation: is it a heartbreaker?

J Taylor Hays1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21727229      PMCID： PMC3168613          DOI： 10.1503/cmaj.110804

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

Review 1.  Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

Authors:  Sonal Singh; Yoon K Loke; John G Spangler; Curt D Furberg
Journal:  CMAJ       Date:  2011-07-04       Impact factor: 8.262

Review 2.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Lindsay F Stead; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

Review 3.  Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

Authors:  Mark J Eisenberg; Kristian B Filion; Daniel Yavin; Patrick Bélisle; Salvatore Mottillo; Lawrence Joseph; André Gervais; Jennifer O'Loughlin; Gilles Paradis; Stephane Rinfret; Louise Pilote
Journal:  CMAJ       Date:  2008-07-15       Impact factor: 8.262

4.  Smoking and smoking cessation in relation to mortality in women.

Authors:  Stacey A Kenfield; Meir J Stampfer; Bernard A Rosner; Graham A Colditz
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

5.  Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.

Authors:  Nancy A Rigotti; Andrew L Pipe; Neal L Benowitz; Carmen Arteaga; Dahlia Garza; Serena Tonstad
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

6.  Mortality in relation to smoking: 50 years' observations on male British doctors.

Authors:  Richard Doll; Richard Peto; Jillian Boreham; Isabelle Sutherland
Journal:  BMJ       Date:  2004-06-22
  6 in total
  6 in total

Review 1.  Pharmacologic agents for tobacco dependence treatment: 2011 update.

Authors:  J Taylor Hays; David D McFadden; Jon O Ebbert
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

2.  Strategies to help a smoker who is struggling to quit.

Authors:  Nancy A Rigotti
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

Review 3.  Medications for substance use disorders.

Authors:  Antoine B Douaihy; Thomas M Kelly; Carl Sullivan
Journal:  Soc Work Public Health       Date:  2013

Review 4.  Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Lee H Sterling; Sarah B Windle; Kristian B Filion; Lahoud Touma; Mark J Eisenberg
Journal:  J Am Heart Assoc       Date:  2016-02-22       Impact factor: 5.501

Review 5.  Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.

Authors:  Judith J Prochaska; Joan F Hilton
Journal:  BMJ       Date:  2012-05-04

Review 6.  Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence.

Authors:  Michael V Burke; J Taylor Hays; Jon O Ebbert
Journal:  Patient Prefer Adherence       Date:  2016-04-01       Impact factor: 2.711
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.